Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast Echocardiography in CABG
NCT00286559Phase 2Withdrawn
- Sponsor
- University Hospital Basel
- Start
- Aug 2006
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
A Phase 2 trial of sulfur hexafluoride, perflutren lipid microspheres in coronary artery disease (CAD), sponsored by University Hospital Basel. Planned start Aug 2006; status: withdrawn.
02
Drugs
sulfur hexafluorideperflutren lipid microspheres
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00286559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286559.